Alport Syndrome: A Comprehensive Review

被引:8
作者
Adone, Avanti [1 ]
Anjankar, Ashish [2 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Med, Wardha, India
[2] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Biochem, Wardha, India
关键词
anterior lenticonus; sensorineural (sn) hearing loss; x linked recessive; end stage renal disease (esrd); alport syndrome; type iv collagen; DIAGNOSIS;
D O I
10.7759/cureus.47129
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Alport syndrome is an genetic disorder that distresses the basement membrane of the kidneys and can also impact other organs, such as the cochlea of the inner ear and eyes. It is characterized by mutation causing abnormalities in the collagen within the basement membrane, which has a crucial role in the filtration process of the kidneys. These abnormalities lead to progressive kidney damage and often result in chronic kidney disease. In some cases of Alport syndrome, the abnormal collagen can also affect the cochlea in the inner ear, leading to sensorineural hearing loss. Additionally, changes in the ocular lens, named anterior lenticonus, can occur, causing vision problems. Alport syndrome can manifest differently among individuals, and its severity can vary. Some people may experience mild symptoms, while others may develop more severe kidney problems, including end-stage renal disease, which may need dialysis or kidney transplant. Treatment for Alport syndrome primarily focuses on managing its symptoms and complications. Regular monitoring of kidney function and blood pressure, along with medications to control hypertension, are crucial aspects of the management plan. In cases of severe kidney damage, kidney transplantation may be necessary. As with any medical condition, early detection and intervention can improve results and quality of life for persons with Alport syndrome. Therefore, if there is a family history of the disorder or any concerning symptoms, it is essential to seek medical attention promptly. Genetic testing can help confirm the diagnosis and identify affected family members, allowing for appropriate monitoring and management.
引用
收藏
页数:8
相关论文
共 32 条
  • [1] An X G, 2016, Zhonghua Er Ke Za Zhi, V54, P669, DOI 10.3760/cma.j.issn.0578-1310.2016.09.008
  • [2] Barker DF, 1996, AM J HUM GENET, V58, P1157
  • [3] IDENTIFICATION OF MUTATIONS IN THE COL4A5 COLLAGEN GENE IN ALPORT SYNDROME
    BARKER, DF
    HOSTIKKA, SL
    ZHOU, J
    CHOW, LT
    OLIPHANT, AR
    GERKEN, SC
    GREGORY, MC
    SKOLNICK, MH
    ATKIN, CL
    TRYGGVASON, K
    [J]. SCIENCE, 1990, 248 (4960) : 1224 - 1227
  • [4] Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study
    Furlano, Monica
    Martinez, Victor
    Pybus, Marc
    Arce, Yolanda
    Crespi, Jaume
    Venegas, Maria del Prado
    Bullich, Gemma
    Domingo, Andrea
    Ayasreh, Nadia
    Benito, Silvia
    Lorente, Laura
    Ruiz, Patricia
    Gonzalez, Vanesa Lopez
    Arlandis, Rosa
    Cabello, Elisa
    Torres, Ferran
    Guirado, Lluis
    Ars, Elisabet
    Torra, Roser
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (04) : 560 - U82
  • [5] Contemporary diagnostic approach in Alport's syndrome
    Grünfeld, JP
    [J]. RENAL FAILURE, 2000, 22 (06) : 759 - 763
  • [6] Diagnosis of Alport syndrome without biopsy?
    Gubler, Marie Claire
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (05) : 621 - 625
  • [7] Hertz JM, 2009, DAN MED BULL, V56, P105
  • [8] Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically
    Imafuku, Aya
    Nozu, Kandai
    Sawa, Naoki
    Hasegawa, Eiko
    Hiramatsu, Rikako
    Kawada, Masahiro
    Hoshino, Junichi
    Tanaka, Kiho
    Ishii, Yasuo
    Takaichi, Kenmei
    Fujii, Takeshi
    Ohashi, Kenichi
    Iijima, Kazumoto
    Ubara, Yoshifumi
    [J]. NEPHROLOGY, 2018, 23 (10) : 940 - 947
  • [9] Jais JP, 2000, J AM SOC NEPHROL, V11, P649, DOI 10.1681/ASN.V114649
  • [10] Kashtan C.E., 2019, GeneReviews